Home › Funds › Unisphere Establishment › BSX
Unisphere Establishment position in BSX
BOSTON SCIENTIFIC CORP · Health Care
Unisphere Establishment reported holding 2,387,800 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$101.9M, representing 0.87% of its reported portfolio and ranking #26 among its reported holdings. Unisphere Establishment has disclosed BSX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Unisphere Establishment's BSX position evolved
Unisphere Establishment first disclosed a stake in BSX in Q4 2023 at 2,325,500 shares (US$134.4M). The position peaked in Q1 2025 at 2,166,400 shares, worth US$218.5M. Across 11 filings, Unisphere Establishment increased the stake 5 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,387,800 shares valued at US$101.9M — a reduction of -414,900 shares quarter over quarter.. Notable position changes include a 29% increase in Q1 2026 (shares fell 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 2.33M | $134.44M | New |
| Q1 2024 | 2.33M | $159.27M | Hold |
| Q2 2024 | 2.44M | $187.67M | Add |
| Q3 2024 | 2.17M | $181.54M | Reduce |
| Q4 2024 | 2.39M | $213.60M | Add |
| Q1 2025 | 2.17M | $218.55M | Reduce |
| Q2 2025 | 1.97M | $211.21M | Reduce |
| Q3 2025 | 2.11M | $205.73M | Add |
| Q4 2025 | 2.18M | $207.55M | Add |
| Q1 2026 | 2.80M | $175.87M | Add |
| Q2 2026 | 2.39M | $101.91M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- Banque Cantonale Vaudoise 67.61K sh · $2.89B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 50.52M sh · $2.16B · Q2 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
- Bollard Group LLC 18.42M sh · $786.20M · Q2 2026
More on Unisphere Establishment
FAQ
How long has Unisphere Establishment held BSX?
Unisphere Establishment has disclosed BSX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is Unisphere Establishment's current position in BSX?
As of Q2 2026, Unisphere Establishment holds 2.39M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $101.91M, representing 0.87% of its reported portfolio and ranking #26.
Has Unisphere Establishment been buying or selling BSX?
In the latest 13F filing (Q2 2026), Unisphere Establishment reduced its position in BSX. The position peaked in Q1 2025 at 2.17M shares.
Which other funds hold BSX?
Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.